← Open Payments lookup

EMMANUEL FANTONE: Open Payments

NPI 1871632547 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,003 in 167 payments from 11 companies in 2025. Trend: 2023 $2,982 · 2024 $1,596 · 2025 $4,003

Food & beverage: $3,753Education: $250
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)43$725
E.R. Squibb & Sons, L.L.C.16$712
Teva Pharmaceuticals USA, Inc.14$576
Alkermes, Inc.21$509
Vanda Pharmaceuticals Inc.22$355
Otsuka America Pharmaceutical, Inc.13$286
ABBVIE INC.10$224
Janssen Pharmaceuticals, Inc9$215
Axsome Therapeutics, Inc.8$150
Neurocrine BioSciences, Inc.6$138

Products named: CAPLYTA, COBENFY, ARISTADA, FANAPT, UZEDY, VRAYLAR, INVEGA SUSTENNA, REXULTI.

Industry payments across CA — which companies pay providers there.